Ranked #1
Peter Menziuso, JJV President, North America Vision Care, Lobbying for Protections in the Contact Lens Rule
Peter Menziuso, JJV President, North America Vision Care, Lobbying for Protections in the Contact Lens Rule
Peter Menziuso, president, North America Vision Care, Johnson & Johnson Vision, discusses J&J’s efforts to lobby... Read more
22 Aug 2018
•
29mins
Ranked #2
Paul Karpecki Sees ‘a Lot of Opportunity’ to Grow Treatment of Dry Eye and Other Ocular Diseases
Paul Karpecki Sees ‘a Lot of Opportunity’ to Grow Treatment of Dry Eye and Other Ocular Diseases
Paul Karpecki thought his odds were pretty good at the start of his career, but an early setback put him on a path that’... Read more
5 Feb 2019
•
20mins
Similar Podcasts
Ophthalmology off the Grid by Eyetube
New Retina Radio by Eyetube
White Coat Investor Podcast
The Retina Channel Podcast
JAMA Ophthalmology Author Interviews
How I Built This with Guy Raz
Ophthalmology Interventional Mindset
Up First
Planet Money
Straight From The Cutter's Mouth: A Retina Podcast
Making Sense with Sam Harris
The Daily
Freakonomics Radio
Experts InSight
The Indicator from Planet Money
Ranked #3
Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire Xiidra
Novartis’ Patrick Mooney Gives Inside Look on the Impact of Alcon Spin-Out, Bid to Acquire Xiidra
Patrick Mooney, head of Novartis’ US eye care business, lays out Novartis’ plans following the spin-out of Alcon and bid... Read more
14 May 2019
•
23mins
Ranked #4
J&J’s Tom Frinzi Provides Updates on Innovation Efforts & More
J&J’s Tom Frinzi Provides Updates on Innovation Efforts & More
In this episode of the OIS Podcast, Dr. Ehsan Sadri sits down with industry veteran Tom Frinzi to learn about Johnson &a... Read more
4 Sep 2019
•
20mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Mitro Opens Up About Aerie’s Programs
Mitro Opens Up About Aerie’s Programs
Tom Mitro of Aerie Pharmaceuticals opens up to OIS Podcast host Ehsan Sadri, MD, about the company’s key programs, inclu... Read more
10 Jul 2019
•
24mins
Ranked #6
Glaukos COO Calcaterra Lays out Pipeline Plans Following iStent inject OK, Reacts to CyPass Recall
Glaukos COO Calcaterra Lays out Pipeline Plans Following iStent inject OK, Reacts to CyPass Recall
Chris Calcaterra, COO of Glaukos, revisits the company’s recent good fortune at the FDA, which approved its second gener... Read more
13 Sep 2018
•
24mins
Ranked #7
Surgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump Netflix
Surgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump Netflix
Ask renowned vitreoretinal surgeon and inventor Steve Charles, MD, if he considers himself a surgeon or engineer first a... Read more
13 Jun 2018
•
35mins
Ranked #8
J&J Vision’s Newly Appointed Worldwide President of Surgical, Mr. Warren Foust Meets with OIS Podcast
J&J Vision’s Newly Appointed Worldwide President of Surgical, Mr. Warren Foust Meets with OIS Podcast
This past week OIS Podcast host, Dr. Ehsan Sadri had the opportunity to chat with J&J Vision’s newly appointed World... Read more
14 Jan 2020
•
13mins
Ranked #9
BONUS EPISODE: Direct from OIS@SECO - Industry Leaders Speaking Out on the Optometric Channel
BONUS EPISODE: Direct from OIS@SECO - Industry Leaders Speaking Out on the Optometric Channel
Industry leaders say optometry presents an enormous opportunity for eye care companies.Participants:Joseph Boorady, OD, ... Read more
28 Feb 2019
•
27mins
Ranked #10
Innovation Starts at Home
Innovation Starts at Home
Emmett Cunningham talks with Suzana Nahum-Zilberberg about the robust innovation scene in Israel, and how she and co-cha... Read more
19 Feb 2020
•
13mins
Ranked #11
REGENXBIO CEO Ken Mills Shines Light on Promising Phase I Trials for Wet AMD Gene Therapy RGX-314
REGENXBIO CEO Ken Mills Shines Light on Promising Phase I Trials for Wet AMD Gene Therapy RGX-314
REGENXBIO founding CEO Ken Mills reviews the company’s recent positive Phase I results for RGX-314, a potentially game-c... Read more
15 Aug 2018
•
39mins
Ranked #12
Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential
Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential
Avedro Inc. went public on Feb. 14, raising $70 million with its shares pricing at, coincidentally, $14. We talk with Re... Read more
24 Apr 2019
•
31mins
Ranked #13
Doug Foster, Chief Strategy Officer of Verana Health, Explains Plans to Replicate IRIS Partnership
Doug Foster, Chief Strategy Officer of Verana Health, Explains Plans to Replicate IRIS Partnership
Verana Health, once known as DigiSight, has been working to make AAO’s EHR database available to commercial partners. No... Read more
8 Aug 2018
•
29mins
Ranked #14
CEO Sean Ianchulev Shares Eyenovia's Plans to Replace Eye Drops with New Microdosing Technology
CEO Sean Ianchulev Shares Eyenovia's Plans to Replace Eye Drops with New Microdosing Technology
The last time we connected with Sean Ianchulev, MD, MPH, he shared Transcend's ultimately winning story. Now, he's the C... Read more
31 May 2018
•
36mins
Ranked #15
Oyster Point Pharma CEO Nau Takes a Deeper Dive into Just-Released PEARL Trial Results
Oyster Point Pharma CEO Nau Takes a Deeper Dive into Just-Released PEARL Trial Results
With Oyster Point Pharma announcing results from the Phase IIb PEARL study, company president and CEO Jeffrey Nau, PhD, ... Read more
12 Jul 2018
•
23mins
Ranked #16
Skimming the Ocular Surface with TFOS’ Amy Gallant Sullivan and Purdue Researcher Chi Hwan Lee
Skimming the Ocular Surface with TFOS’ Amy Gallant Sullivan and Purdue Researcher Chi Hwan Lee
This week the OIS Podcast skims the ocular surface with two interviews. First, we talk with Amy Gallant Sullivan, execut... Read more
18 Jul 2018
•
38mins
Ranked #17
Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path
Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path
Former Aerie CMO Brian Levy, OD, was settling down for a quieter life in Florida when he came upon OcuNexus, a biopharma... Read more
20 Feb 2019
•
43mins
Ranked #18
Wall Street Analyst David Nierengarten of Wedbush Dissects Recent Gene Therapy Shopping Spree
Wall Street Analyst David Nierengarten of Wedbush Dissects Recent Gene Therapy Shopping Spree
Together, Roche and Biogen paid over $5.5 billion for gene therapy companies Spark and Nightstar. What does this mean fo... Read more
13 Mar 2019
•
22mins
Ranked #19
Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline
Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline
Oculis CEO Riad Sherif, who once worked for Novartis and Alcon, reveals which company he’d invest in following the spin-... Read more
17 Apr 2019
•
18mins
Ranked #20
Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO
Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO
With more than $100 million raised in venture capital and three late-stage clinical programs, Oyster Point Pharma is get... Read more
10 Apr 2019
•
31mins
